ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0864

Proteomic Analysis of Circulating Neutrophils from Osteoarthritis Patients Shows Metabolic Dysregulation That Is Associated with Decreased Physiologic Apoptosis

Jennifer Amsler1, Morgane Le Gall2, Camille Daste3, François Rannou3 and Véronique Witko-Sarsat2, 1Institut Cochin, Bern, Switzerland, 2Institut Cochin, Paris, France, 3Hôpital Cochin, Paris, France

Meeting: ACR Convergence 2023

Keywords: Apoptosis, Cell Death, Inflammation, neutrophils, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0859–0885) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) has long been thought to be only of local mechanical origin. However, it has been shown recently that there is a phenotype of OA with inflammatory properties. Here, we hypothesize that circulating neutrophils could be involved in disease pathogenesis suggesting a systemic involvement in this “local” disease.

Methods: We investigated the cytosolic proteome of blood neutrophils from four OA patients with an inflammatory knee osteoarthritis and compared it to the cytosolic proteome of blood neutrophils from three healthy controls (HC) of similar age. Functional analysis was generated through the use of the software Ingenuity Pathway Analysis (IPA). We further investigated in vitro the physiological apoptosis of isolated circulating neutrophils from OA patients compared to neutrophils from HC and measured the glycogen content in neutrophil cytosol.

Results: Based on the differentially regulated proteins, IPA predicts a downregulation of the glycogen degradation pathway as the most important difference between blood neutrophils from OA patients and those from HC, suggesting a disturbance in glycogen storage or use in OA neutrophils. Further, IPA predicts an inhibition of cell death of immune cells and an activation of senescence of cells. One of the differentially regulated proteins involved in survival is PCNA, which is found to be increased in neutrophils from OA patients. When measuring the glycogen content in blood neutrophils from OA patients compared with that from HC, we found no difference in glycogen content. However, we found a significant difference in the content of glycogen between neutrophils at a basal state and apoptotic neutrophils in both groups, suggesting that neutrophils use glycogen during their apoptosis. There was no correlation between the basal glycogen concentration of the cells and the percentage of apoptosis in neutrophils from both HC and OA, suggesting that the initial glycogen concentration has not a direct impact on the process of apoptosis of neutrophils. Preliminary results of Annexin-V labeling showed that neutrophils from OA patients have a significant delayed apoptosis compared with HC.

Conclusion: Our findings uncover for the first time a dysregulation in circulating neutrophils in OA that could have an impact on the disease pathogenesis and demonstrate a systemic involvement in OA. We provide evidence that cytosolic proteins of circulating neutrophils of OA patients are disturbed in terms of glycogen metabolism and apoptosis, which might result in a higher survival rate. Molecular mechanisms underlying these disturbances remain to be elucidated.

Supporting image 1

Figure 1: Heat map of differentially expressed proteins between neutrophil cytosol from blood of healthy control (HC) and osteoarthritis patients (OA). The proteins (rows) and samples (columns) are hierarchically clustered using Pearson correlation and average linkage on z-score quantification intensities. Each number indicates one patient. Color depicts the z-score changes in protein intensities respective to baseline expression levels, red: overexpression and green: underexpression.

Supporting image 2

Figure 2: Specific network of cell death pathway shows differentially expressed proteins in the cytosol of blood neutrophils from OA patients and HC. Red indicates increased measurement of proteins, green indicates decreased measurements of proteins in neutrophils from OA patients compared to HC. Blue and orange indicate predicted inhibition and activation as shown in the colored legend.


Disclosures: J. Amsler: None; M. Le Gall: CHUGAI ROCHE, 6; C. Daste: None; F. Rannou: Eli Lilly, 6, Fidia, 6, Ipsen, 6, Thuasne, 5, 6; V. Witko-Sarsat: None.

To cite this abstract in AMA style:

Amsler J, Le Gall M, Daste C, Rannou F, Witko-Sarsat V. Proteomic Analysis of Circulating Neutrophils from Osteoarthritis Patients Shows Metabolic Dysregulation That Is Associated with Decreased Physiologic Apoptosis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/proteomic-analysis-of-circulating-neutrophils-from-osteoarthritis-patients-shows-metabolic-dysregulation-that-is-associated-with-decreased-physiologic-apoptosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proteomic-analysis-of-circulating-neutrophils-from-osteoarthritis-patients-shows-metabolic-dysregulation-that-is-associated-with-decreased-physiologic-apoptosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology